Practical approaches for design and analysis of clinical trials of infertility treatments: Crossover designs and the Mantel-Haenszel method are recommended

Pharmaceutical Statistics

Volumn 14, Issue 3, 2015, Pages 198-204

  Takada, Michihiro ^a   Sozu, Takashi ^b   Sato, Tosiya ^b  

^a Ajinomoto Pharmaceutical CO   (Japan)

^b KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

crossover designs; irreversible endpoints; re randomization designs; the logistic mixture model; the Mantel Haenszel method

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); CROSSOVER PROCEDURE; FEMALE; HUMAN; INFERTILITY THERAPY; MANTEL HAENSZEL TEST; PREGNANT WOMAN; SAMPLE SIZE; SIMULATION; THERAPY EFFECT; INFERTILITY, FEMALE; METHODOLOGY; ODDS RATIO; PREGNANCY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; STATISTICAL ANALYSIS; STATISTICAL BIAS; STATISTICAL MODEL; TREATMENT OUTCOME;

FERTILITY PROMOTING AGENT;

BIAS (EPIDEMIOLOGY); CROSS-OVER STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; LOGISTIC MODELS; MODELS, STATISTICAL; ODDS RATIO; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84929089723     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1674     Document Type: Article

References (16)

1. Cohlen BJ, te Velde ER, Looman CW, Eijckemans R, Habbema JD,. Crossover or parallel design in infertility trials? The discussion continues. Fertility and Sterility 1998; 70: 40-45.
2. Norman GR, Daya S,. The alternating-sequence design (or multiple-period crossover) trial for evaluating treatment efficacy in infertility. Fertility and Sterility 2000; 74: 319-324.
3. Senn S,. Cross-over Trials in Clinical Research, Second Edition. Wiley: Chichester, 2002.
4. Dubey SD,. Current thoughts on cross-over designs. Clinical Research and Regulatory Affairs 1986; 4: 127-142.
5. Guidance for Industry, Clinical Investigators, Institutional Review Boards and Food and Drug Administration Staff. Design Considerations for Pivotal Clinical Investigations for Medical Devices. Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD, 2013.
6. Gregoriou O, Vitorators N, Papadias C, Konidaris S, Gargaropolos A, Rizos D,. Pregnancy rates in gonadotrophin stimulated cycles with timed intercourse or intrauterine insemination for the treatment of male subfertility. European Journal of Obstetrics & Gynecology and Reproductive Biology 1996; 64: 213-216.
7. Nulsen JC, Walsh S, Dumez S, Metzger DA,. A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obsterics and Gynecology 1993; 82: 780-786.
8. Makubate B, Senn S,. Planning and analysis of cross-over trials in infertility. Statistics in Medicine 2010; 29: 3203-3210.
9. Nason M, Follmann D,. Design and analysis of crossover trials for absorbing binary endpoints. Biometrics 2010; 66: 958-965.
10. Cohlen BJ, te Velde ER, van Kooij RJ, Looman CW, Habbema JD,. Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study. Human Reproduction 1998; 13: 1553-1558.
11. Mantel N, Haenszel W,. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959; 22: 719-748.
12. Hauck WW, Neuhans JM, Kalbfleisch JD, Anderson S,. A consequence of omitted covariates when estimating odds ratios. Journal of Clinical Epidemiology 1991; 44: 77-81.
13. Walter WS,. Generalized Linear Mixed Models, Methods and Applications. Chapman and Hall/CRC Text in Statistical Science: Boca Raton, FL, 2013.
14. Sato T,. Confidence limits for the common odds ratio based on the asymptotic distribution of the Mantel-Haenszel estimator. Biometrics 1990; 46: 71-80.
15. Greenland S, Robins JM,. Estimation of a common effect parameter from sparse follow-up data. Biometrics 1985; 41: 55-68.
16. Sato T,. On variance estimator for the Mantel-Haenszel risk difference. (Letter). Biometrics 1989; 45: 1323-1324.